melanoma

Groundbreaking discovery may lead to new treatments for epithelial cancersNow, scientists know how one gene mutation leads to skin cancer — as well as other epithelial cancers such as lung, esophagus, mouth and throat. This groundbreaking discovering may lead to the development of new treatments and clinical trials.
Common Staph strain on skin protects against skin neoplasiaA strain of Staphylococcus epidermidis, a common microbe on healthy human skin, produces a chemical compound that has the ability to impair growth of skin neoplasia, researchers have found.
Skin assessment key to identifying internal malignancyBecause skin metastasis is usually asymptomatic, conducting thorough skin assessments is critical for timely diagnosis of internal malignancy, researchers write in The Journal for Nurse Practitioners.
Inhibitors found to benefit surgically resectable melanomaTreatment significantly improved event-free survival in patients with high-risk, surgically resectable, clinical stage III and IV melanoma, researchers report.
From new vaccines to the advent of new neurotoxinsPhysicians weigh in expectations for new developments within all facets of dermatology from pediatric dermatology to dermatopathology.
Ruler is better than eye for pigment measurePhysicians should measure pigmented lesion diameter with a ruler rather than estimating via landmarks or the naked eye, a study shows.
Challenging skin cancer diagnoses
Challenging skin cancer diagnosesIn this installment of our melanoma case studies series, we focus on common cancers in unusual locations versus uncommon cancers in classic locations.
FDA approves breakthrough cancer gene test
FDA approves breakthrough cancer gene testFDA approved a new cancer biomarker test that can detect genetic mutations in 324 genes and 2 genomic signatures in tumors.
Melanoma research roundupIn this slideshow, we highlight recently published research findings on newly identified genetic mutations associated with conjunctival melanoma, expanding the definition of melanoma to include population diversities, and dermatomyositis that fails treatment.
Revised melanoma staging criteriaStaging system is derived from a new dataset of patients from 10 cancer centers around the world. Dermatologists should consider AJCC tumor characteristics as well as other factors in risk assessment, counseling, and follow-up plans for patients. Update takes effect in January 2018.